Poonguzhali Elangovan

Dr. Poonguzhali Elangovan

DEAL, Mayo Clinic, Jacksonville, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2020 in International Journal of Imaging Systems and Technology
Verified
Journal Article
Closed access
PDF file
Poonguzhali ElangovanPoonguzhali Elangovan
Poonguzhali Elangovan
MALAYA KUMAR NATHMALAYA KUMAR NATH
MALAYA KUMAR NATH

24 May 2022 in International Journal of Imaging Systems and Technology
Verified
Journal Article
Closed access
Poonguzhali ElangovanPoonguzhali Elangovan
Poonguzhali Elangovan
MALAYA KUMAR NATHMALAYA KUMAR NATH
MALAYA KUMAR NATH

29 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SCSwathi Priya Cherukuri
Swathi Priya Cherukuri
Anmolpreet KaurAnmolpreet Kaur
Anmolpreet Kaur
BGBipasha Goyal
Bipasha Goyal
HKHanisha Reddy Kukunoor
Hanisha Reddy Kukunoor
ASAreesh Sahito
Areesh Sahito
Shivaram P. ArunachalamShivaram P. Arunachalam
Shivaram P. Arunachalam
Background: Lung cancer remains the leading cause of cancer-related mortality globally, largely due to delayed diagnosis in its early stages. While conventional diagnostic tools like low-dose CT and tissue biopsy are routinely used, they suffer from limitations including invasiveness, radiation exposure, cost, and limited sensitivity for early-stage detection. Liquid biopsy, a minimally invasive alternative that captures circulating tumor-derived biomarkers such as ctDNA, cfRNA, and exosomes from body fluids, offers promising diagnostic potential—yet its sensitivity in early disease remains suboptimal. Recent advances in Artificial Intelligence (AI) and radiomics are poised to bridge this gap. Objective: This review aims to explore how AI, in combination with radiomics, enhances the diagnostic capabilities of liquid biopsy for early detection of lung cancer and facilitates personalized monitoring strategies. Content Overview: We begin by outlining the molecular heterogeneity of lung cancer, emphasizing the need for earlier, more accurate detection strategies. The discussion then transitions into liquid biopsy and its key analytes, followed by an in-depth overview of AI techniques—including machine learning (e.g., SVMs, Random Forest) and deep learning models (e.g., CNNs, RNNs, GANs)—that enable robust pattern recognition across multi-omics datasets. The role of radiomics, which quantitatively extracts spatial and morphological features from imaging modalities such as CT and PET, is explored in conjunction with AI to provide an integrative, multimodal approach. This convergence supports the broader vision of precision medicine by integrating omics data, imaging, and electronic health records. Discussion: The synergy between AI, liquid biopsy, and radiomics signifies a shift from traditional diagnostics toward dynamic, patient-specific decision-making. Radiomics contributes spatial information, while AI improves pattern detection and predictive modeling. Despite these advancements, challenges remain—including data standardization, limited annotated datasets, the interpretability of deep learning models, and ethical considerations. A push toward rigorous validation and multimodal AI frameworks is necessary to facilitate clinical adoption. Conclusion: The integration of AI with liquid biopsy and radiomics holds transformative potential for early lung cancer detection. This non-invasive, scalable, and individualized diagnostic paradigm could significantly reduce lung cancer mortality through timely and targeted interventions. As technology and regulatory pathways mature, collaborative research is crucial to standardize methodologies and translate this innovation into routine clinical practice.

17 July 2021 in SN Computer Science
Verified
Journal Article
Closed access
PDF file
Poonguzhali ElangovanPoonguzhali Elangovan
Poonguzhali Elangovan
MALAYA KUMAR NATHMALAYA KUMAR NATH
MALAYA KUMAR NATH

11 December 2023 in Circuits, Systems, and Signal Processing
Verified
Journal Article
Closed access
PDF file
Poonguzhali ElangovanPoonguzhali Elangovan
Poonguzhali Elangovan
DVD Vijayalakshmi
D Vijayalakshmi
MALAYA KUMAR NATHMALAYA KUMAR NATH
MALAYA KUMAR NATH

9 July 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Poonguzhali ElangovanPoonguzhali Elangovan
Poonguzhali Elangovan
DVD Vijayalakshmi
D Vijayalakshmi
MALAYA KUMAR NATHMALAYA KUMAR NATH
MALAYA KUMAR NATH
PYPratheepan Yogarajah
Pratheepan Yogarajah
Joan CondellJoan Condell
Joan Condell
The rising awareness of nutritional values has led to an increase in the popularity of meat-based diets. Hence, to ensure public health, industries and consumers are focusing more on the quality and freshness of this food. Authentic meat quality assessment methods can indeed be exorbitant and catastrophic. Furthermore, it is subjective and reliant on the knowledge of specialists. Fully automated computer-aided diagnosis systems are required to eradicate the variability among experts. However, evaluating the quality of meat automatically is challenging. Deep convolutional neural networks have shown a tremendous improvement in meat quality assessment. This research intends to utilize an ensemble framework of shallow convolutional neural networks for assessing the quality and freshness of the meat. Two compact CNN architectures (ConvNet-18 and ConvNet-24) are developed, and the efficacy of the models are evaluated using two publicly available databases. Experimental findings reveal that the ConvNet-18 outperforms other state-of-the models in classifying fresh and spoiled meat with an overall accuracy of 99.4%, whereas ConvNet-24 shows a better outcome in categorizing the meat based on its freshness. This model yields an accuracy of 96.6%, which is much better compared with standard models. Furthermore, the suggested models effectively detect the quality and freshness of the meat with less complexity than the existing state-of-the art techniques.